aldosterone has been researched along with Myasthenia Gravis in 9 studies
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GOTTLIEB, B | 1 |
| LAURENT, LP | 1 |
| DILORENZO, M | 1 |
| JACOBELLI, A | 1 |
| MALIZIA, E | 1 |
| JEUNE, M | 1 |
| VINCENT, P | 1 |
| HUMBERT, G | 1 |
| LEVRAT, R | 1 |
| PIETTE, Y | 1 |
| VERHELST, S | 1 |
| PLAUCHU, M | 1 |
| DALMAIS, J | 1 |
| BUSSY, L | 1 |
| TETE, R | 1 |
| MOULINIER, B | 1 |
| Cathala, HP | 1 |
| Inada, M | 1 |
| Nishikawa, M | 1 |
| Oishi, M | 1 |
| Kurata, S | 1 |
| Ogawa, H | 1 |
| Sakurami, T | 1 |
| Kono, T | 1 |
| Imura, H | 1 |
| Nakamoto, M | 2 |
| Kimura, T | 1 |
| Nakamura, Y | 1 |
| Ota, M | 1 |
9 other studies available for aldosterone and Myasthenia Gravis
| Article | Year |
|---|---|
Spironolactone in the treatment of myasthenia gravis.
Topics: Aldosterone; Diuretics; Humans; Mineralocorticoid Receptor Antagonists; Myasthenia Gravis; Spironola | 1961 |
[FINDINGS ON THE URINARY EXCRETION OF ALDOSTERONE IN MYASTHENIA GRAVIS].
Topics: Aldosterone; Blood Chemical Analysis; Body Fluids; Humans; Ions; Myasthenia Gravis; Potassium; Sodiu | 1963 |
[Preliminary note on the use of a spirolactone in the treatment of myasthenia].
Topics: Aldosterone; Humans; Mineralocorticoid Receptor Antagonists; Muscle Weakness; Myasthenia Gravis; Spi | 1962 |
[Myasthenia gravis and spironolactone].
Topics: Aldosterone; Humans; Mineralocorticoid Receptor Antagonists; Myasthenia Gravis; Progesterone; Spiron | 1962 |
[Apropos of a case of myasthenia gravis improved by spirolactones].
Topics: Aldosterone; Humans; Mineralocorticoid Receptor Antagonists; Myasthenia Gravis; Spironolactone | 1962 |
[Treatment of myasthenia].
Topics: Aldosterone; Cholinesterase Inhibitors; Humans; Myasthenia Gravis; Thymectomy | 1967 |
Bartter's syndrome associated with Graves' disease and myasthenia gravis: report of a case.
Topics: Adult; Aldosterone; Angiotensin II; Azathioprine; Bartter Syndrome; Blood Pressure; Graves Disease; | 1978 |
[Clinical studies on the urinary excretion of aldosterone in myasthenia gravis].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adult; Aldosterone; Ambenonium Chloride; Cat | 1967 |
Urinary excretion of aldosterone in myasthenia gravis.
Topics: Adolescent; Adult; Aldosterone; Child; Female; Humans; Male; Middle Aged; Myasthenia Gravis | 1966 |